Step into Zhuoyi
A Warm Gathering in Autumn: Zhuoyi Bio’s 2025 Trade Union Autumn Outing Concludes Successfully
Release Date:
2025-09-23
- About Zhuoyi Bio -
Zhuoyi uses human‑derived strains, ensuring greater efficacy through shared origins; Zhuoyi employs Vero cells, offering enhanced safety with no tumor‑forming potential; Zhuoyi features VVM labeling, providing visible assurance of safety and effectiveness; and Zhuoyi’s rabies vaccine is patented, with zero added antibiotics for added peace of mind.
Zhuoyi Biologics adheres to the philosophy of “Healthier, More Professional,” and is committed to becoming a global vaccine manufacturer that delivers superior quality, broad accessibility, and sustainable development, contributing Zhuoyi’s strength to Healthy China and the advancement of global public health.